scholarly article | Q13442814 |
P356 | DOI | 10.1097/00002030-199311002-00007 |
P698 | PubMed publication ID | 8161443 |
P2093 | author name string | J J Sninsky | |
S Kwok | |||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | S29-34 | |
P577 | publication date | 1993-11-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | The application of quantitative polymerase chain reaction to therapeutic monitoring | |
P478 | volume | 7 Suppl 2 |
Q39505835 | Comparison of an Amplified Enzyme-Linked Immunosorbent Assay with Procedures Based on Molecular Biology for Assessing Human Immunodeficiency Virus Type 1 Viral Load |
Q42982548 | Comparison of competitive and non-competitive reverse transcription-polymerase chain reaction (RT-PCR) for the quantification of hepatitis C virus (HCV) RNA. |
Q33965139 | Comparison of competitive and positive control-based PCR quantitative procedures coupled with end point detection |
Q73934405 | Development of a RT-PCR test coupled with a microplate colorimetric assay for the detection of a swine Arterivirus (PRRSV) in boar semen |
Q34387001 | Difficulties and strategies of HIV diagnosis |
Q41645720 | Genotypic selection methods for the direct analysis of point mutations |
Q42637939 | Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays |
Q24544717 | Nanoliter scale PCR with TaqMan detection |
Q45754433 | Quantitation of foot-and-mouth disease virus genomes in bovine tissue by competitive RT-PCR |
Q36526526 | Quantitation of human immunodeficiency virus type 1 DNA by two PCR procedures coupled with enzyme-linked oligosorbent assay. |
Q45759163 | Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain |
Q54133163 | The clinical utility of viral quantitation using molecular methods |
Q24655011 | The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic |